Klekota J, Brauner E, Schreiber SL. Identifying biologically active compound classes using phenotypic screening data and sampling statistics. J Chem Inf Model. 2005;45(6):1824-36. doi:10.1021/ci050087d.

Chen L-Q, Luo J-H, Cui Z-H, et al. , , and Encode Putative H3K4 Methyltransferases and Are Critical for Plant Development. Plant Physiol. 2017;174(3):1795-1806. doi:10.1104/pp.16.01944.

Garone C, D’Souza AR, Dallabona C, et al. Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome. Hum Mol Genet. 2017;26(21):4257-4266. doi:10.1093/hmg/ddx314.

Onder TT, Kara N, Cherry A, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012;483(7391):598-602. doi:10.1038/nature10953.

Ichida JK, TCW J, Williams LA, et al. Notch inhibition allows oncogene-independent generation of iPS cells. Nat Chem Biol. 2014;10(8):632-639. doi:10.1038/nchembio.1552.

Schwartz S, Mumbach MR, Jovanovic M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5’ sites. Cell Rep. 2014;8(1):284-96. doi:10.1016/j.celrep.2014.05.048.

Chen C-W, Koche RP, Sinha AU, et al. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat Med. 2015;21(4):335-43. doi:10.1038/nm.3832.

Kim J, Xiao H, Koh J, et al. Determinants of the CmoB carboxymethyl transferase utilized for selective tRNA wobble modification. Nucleic Acids Res. 2015;43(9):4602-13. doi:10.1093/nar/gkv206.